Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau – An Open-Label Non-Inferiority Randomised Clinical Trial

• Johan Ursing ,

  * E-mail: johan.ursing@ds.se (JU); poul.erik.kofoed@rsyd.dk (PEK)

  Affiliations Projecto de Saúde de Bandim, Indepth Network, Bissau, Guinea-Bissau, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet Nobels väg 16, 171 65, Stockholm, Sweden, Department of Infectious Diseases, Danderyds Hospital, Stockholm, Sweden

  ⨯
• Lars Rombo,

  Affiliations Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet Nobels väg 16, 171 65, Stockholm, Sweden, Centre for Clinical Research, Sörmland county council, Eskilstuna, Sweden and Uppsala University, Uppsala, Sweden

  ⨯
• Amabelia Rodrigues,

  Affiliation Projecto de Saúde de Bandim, Indepth Network, Bissau, Guinea-Bissau

  ⨯
• Poul-Erik Kofoed

  * E-mail: johan.ursing@ds.se (JU); poul.erik.kofoed@rsyd.dk (PEK)

  Affiliations Projecto de Saúde de Bandim, Indepth Network, Bissau, Guinea-Bissau, Department of Paediatrics, Kolding Hospital, Kolding, Denmark

  ⨯